Product Data Sheet

SARS-CoV-2 3CLpro-IN-21

Catalog No. A53523

main product photo
SARS-CoV-2 3CLpro-IN-21 is an irreversible and covalent inhibitor of the SARS-CoV-2 3CL protease, exhibiting an IC50 of 0.03 µM. Additionally, it demonstrates activity against the SARS-CoV-1 3CLpro with an IC50 of 0.12 µM. This compound is valuable for investigative research into viral protease inhibition and potential therapeutic strategies against SARS-CoV-2 infections.
Chemical Information
Catalog NumA53523
M. Wt364.22
FormulaC14H10BrN3O2S
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.3052835-22-7
Synonyms
SMILESBrC1=CC=C(C=C1)C2=NN=C(O2)S(CC3=CN=CC=C3)=O
Biological Activity
DescriptionSARS-CoV-2 3CLpro-IN-21 is an irreversible and covalent inhibitor of the SARS-CoV-2 3CL protease, exhibiting an IC50 of 0.03 µM. Additionally, it demonstrates activity against the SARS-CoV-1 3CLpro with an IC50 of 0.12 µM. This compound is valuable for investigative research into viral protease inhibition and potential therapeutic strategies against SARS-CoV-2 infections.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.